Barco N.V.

Barco reported first-half 2026 orders of EUR 468 million, down 4% year over year, or flat at constant currency. Sales were EUR 418 million, down 8% reported and 3% at constant currency. EBITDA was EUR 26 million, equal to 6% of sales, and net result was -EUR 4.8 million. Free cash flow was -EUR 37 million, with gross operating free cash flow of EUR 20 million. Gross profit margin was described as resilient despite product mix effects, recurring revenues reached 13% of sales, and the order book ended at EUR 568 million, up EUR 67 million from the beginning of the year. Full-year 2026 guidance was reaffirmed for sales above last year, including VerVent Audio Holding, and an EBITDA margin in the range of 11%-12% (reconfirmed by management as 11%-12%).

CEO An Steegen emphasized that momentum improved in the second quarter after a difficult first quarter, especially in the Americas and in areas like diagnostic imaging and control rooms. She framed the strategy as a shift from hardware toward more software, AI, edge compute, and recurring revenue, and said the company is reinforcing leadership in core markets while focusing investment on structurally growing businesses. On VerVent, she said the acquisition fits Barco’s plan to go “all in on entertainment,” combining visualization and audio to expand the addressable market and create a broader entertainment ecosystem.

CFO Ann Desender said the first-half earnings pressure came mainly from lower sales, FX, and one-offs, while gross profit margin stayed resilient thanks to mix, services, and recurring revenue. She highlighted EUR 57 million higher inventories as the main free-cash-flow drag, driven by advance buying of components and memory chips plus some finished goods held due to softer-than-expected sales. She also noted EUR 15 million of capex, EUR 8.4 million of restructuring costs with about EUR 1 million cash impact, and a shift from net cash to EUR 33 million net debt after the EUR 134 million VerVent cash out, EUR 44 million of dividends, and EUR 11 million of share buybacks.

Analysts focused first on how Barco can get to the second-half earnings implied by guidance, and management said the improvement depends on six months of VerVent contribution, better top-line momentum, resilient gross margin, and cost actions that should have a larger impact in H2. Questions also centered on VerVent’s valuation; management defended the EUR 135 million purchase price by pointing to revenue multiple, strategic fit, and expected synergies, while acknowledging it was “not cheap” and that it is still early days. On healthcare surgical, management explained the weakness as a combination of contract cycles, cost competitiveness, and long design-in timelines with large system integrators, while saying Barco is adapting with mid-end products like Nexxis Cube and lower-cost engineering in China.